Cargando…

Antiviral Treatment for Hepatitis C Virus Infection after Liver Transplantation

A significant proportion of patients with chronic hepatitis C virus (HCV) infection develop liver cirrhosis and complications of end-stage liver disease over two to three decades and require liver transplantation, however, reinfection is common and leads to further adverse events under immunosuppres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugawara, Yasuhiko, Tamura, Sumihito, Kokudo, Norihiro
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989693/ https://www.ncbi.nlm.nih.gov/pubmed/21151523 http://dx.doi.org/10.1155/2010/475746

Ejemplares similares

Impact of Donor and Recipient Single Nucleotide Polymorphisms of IL28B rs8099917 in Living Donor Liver Transplantation for Hepatitis C
por: Harada, Nobuhiro, et al.
Publicado: (2014)

Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft
por: Aoki, Taku, et al.
Publicado: (2012)

Living Donor Liver Transplantation for Patients with Hepatocellular Carcinoma
por: Akamatsu, Nobuhisa, et al.
Publicado: (2014)

Impact of Early Reoperation following Living-Donor Liver Transplantation on Graft Survival
por: Kawaguchi, Yoshikuni, et al.
Publicado: (2014)

Liver Transplantation and Hepatitis C
por: Akamatsu, Nobuhisa, et al.
Publicado: (2012)

Living-Donor Liver Transplantation and Hepatitis C
por: Akamatsu, Nobuhisa, et al.
Publicado: (2013)

Intrahepatic MicroRNA Profile of Liver Transplant Recipients with Hepatitis C Virus Co-Infected with Human Immunodeficiency Virus
por: Miyaaki, Hisamitsu, et al.
Publicado: (2017)

Acquisition of methicillin-resistant Staphylococcus aureus after living donor liver transplantation: a retrospective cohort study
por: Hashimoto, Masao, et al.
Publicado: (2008)

Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation
por: Toniutto, Pierluigi, et al.
Publicado: (2008)

Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2018)

The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real?
por: Strazzulla, Alessio, et al.
Publicado: (2016)

Hereditary Hemorrhagic Telangiectasia with Hepatic Vascular Malformations
por: Nishioka, Yujiro, et al.
Publicado: (2015)

Hepatocellular Carcinoma: Current Management and Future Development—Improved Outcomes with Surgical Resection
por: Kishi, Yoji, et al.
Publicado: (2011)

Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents
por: Cholankeril, George, et al.
Publicado: (2017)

Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation
por: Ueda, Yoshihide, et al.
Publicado: (2013)

Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma
por: Ismail, Mohamed Saleh, et al.
Publicado: (2020)

Sofosbuvir, Velpatasvir, and Voxilaprevir for Treatment of Recurrent Hepatitis C Virus Infection After Liver Transplantation
por: Cardona‐Gonzalez, Maria G., et al.
Publicado: (2018)

Correction: Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation
por: Ueda, Yoshihide, et al.
Publicado: (2013)

Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
por: Rupp, Christian, et al.
Publicado: (2018)

A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis E in Liver Transplant Recipients in Japan
por: Inagaki, Yuki, et al.
Publicado: (2015)

Successful Antiviral Treatment with Direct-Acting Antivirals for Hepatitis C Virus Infection during Peritransplant Period in a Kidney Transplant Recipient
por: Varotti, Giovanni, et al.
Publicado: (2021)

Role of living donor liver transplantation in the treatment of hepatitis C virus infection
por: Tsoulfas, Georgios, et al.
Publicado: (2011)

Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation
por: Reddy, Suresh, et al.
Publicado: (2018)

Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma
por: Nagao, Yumiko, et al.
Publicado: (2017)

Massive duodenal ulcer bleeding due to the ruptured hepatic artery pseudoaneurysm after living donor liver transplantation
por: Kadohisa, Masashi, et al.
Publicado: (2022)

Living donor domino liver transplantation in a hepatitis C virus/human immunodeficiency virus-coinfected hemophilia patient: a case report
por: Yamamoto, Hidekazu, et al.
Publicado: (2020)

Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells
por: Rehman, Sidra, et al.
Publicado: (2011)

Increased and More Heterogeneous Gadoxetic Acid Uptake of the Liver Parenchyma after Hepatitis C Virus Eradication by Direct Antiviral Agent
por: Fujita, Nobuhiro, et al.
Publicado: (2020)

The Impact of Antiviral Treatment of Hepatitis B Virus after Kidney Transplant and the Latest Insights
por: Fabrizi, Fabrizio, et al.
Publicado: (2023)

Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection
por: Reau, Nancy, et al.
Publicado: (2018)

Two Cases of Hepatocellular Carcinoma Occurring Immediately after Direct-acting Antiviral Agents against Hepatitis C Virus
por: Nishijima, Norihiro, et al.
Publicado: (2018)

Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience
por: Kim, Jong Man, et al.
Publicado: (2018)

Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma
por: Ismail, Mohamed Saleh, et al.
Publicado: (2021)

Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
por: Kanda, Tatsuo, et al.
Publicado: (2014)

Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients
por: Llorens-Revull, Meritxell, et al.
Publicado: (2021)

Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates
por: Mehawej, Mireille, et al.
Publicado: (2015)

Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection
por: Lin, Ming V., et al.
Publicado: (2016)

Liver-related effects of chronic hepatitis C antiviral treatment
por: Laursen, Tea L, et al.
Publicado: (2020)

Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection
por: Trifan, Anca, et al.
Publicado: (2023)

Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection
por: Lu, Lun-Gen
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m6vqgspp3kvtd250ho5mtfnjvh